NASDAQ:NUAN - Nuance Communications Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $38.50
  • Forecasted Upside: -8.76 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$42.20
▼ -0.08 (-0.19%)
1 month | 3 months | 12 months
Get New Nuance Communications Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NUAN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NUAN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$38.50
▼ -8.76% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Nuance Communications in the last 3 months. The average price target is $38.50, with a high forecast of $47.00 and a low forecast of $21.00. The average price target represents a -8.76% upside from the last price of $42.20.
Buy
The current consensus among 8 contributing investment analysts is to buy stock in Nuance Communications. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/11/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/7/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/2/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/2/2020

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/30/2020GuggenheimUpgradeNeutral ➝ BuyLow
i
11/19/2020SVB LeerinkBoost Price TargetOutperform$38.00 ➝ $42.00High
i
Rating by S. Demko at SVB Leerink LLC
11/19/2020Craig HallumBoost Price TargetIn-Line ➝ Buy$36.00 ➝ $41.00High
i
11/19/2020WedbushBoost Price TargetOutperform$40.00 ➝ $45.00High
i
11/19/2020BarclaysBoost Price TargetOverweight$40.00 ➝ $47.00High
i
11/16/2020Morgan StanleyBoost Price TargetOverweight$33.00 ➝ $35.00Low
i
11/13/2020SVB LeerinkBoost Price TargetOutperform$33.00 ➝ $38.00Medium
i
Rating by S. Demko at SVB Leerink LLC
9/23/2020WedbushBoost Price TargetHold ➝ Outperform$33.00 ➝ $40.00Medium
i
8/11/2020OppenheimerReiterated RatingBuy$21.00Low
i
8/7/2020SVB LeerinkBoost Price TargetOutperform$31.00 ➝ $33.00Medium
i
Rating by S. Demko at SVB Leerink LLC
8/6/2020CfraDowngradeHold ➝ SellLow
i
8/6/2020Craig HallumBoost Price TargetBuy$25.00 ➝ $36.00Low
i
8/6/2020Morgan StanleyBoost Price TargetOverweight$30.00 ➝ $33.00High
i
8/6/2020WedbushBoost Price TargetOutperform$27.00 ➝ $33.00High
i
7/20/2020BarclaysBoost Price TargetOverweight$23.00 ➝ $30.00High
i
7/16/2020Morgan StanleyBoost Price TargetOverweight$20.00 ➝ $30.00Low
i
Rating by Sanjit Singh at Morgan Stanley
6/29/2020SVB LeerinkInitiated CoverageOutperform$31.00Medium
i
Rating by S. Demko at SVB Leerink LLC
4/14/2020GuggenheimInitiated CoverageNeutralHigh
i
3/25/2020Morgan StanleyLower Price TargetOverweight$24.00 ➝ $20.00Low
i
Rating by Sanjit Singh at Morgan Stanley
2/7/2020WedbushReiterated RatingOutperformLow
i
2/3/2020Morgan StanleyReiterated RatingBuy$23.00Medium
i
Rating by Sanjit Singh at Morgan Stanley
1/22/2020BarclaysReiterated RatingBuy$23.00Low
i
1/21/2020WedbushBoost Price TargetOutperform$24.00 ➝ $27.00Low
i
1/13/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$15.00 ➝ $23.00High
i
12/11/2019OppenheimerReiterated RatingBuy$23.00Low
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
10/7/2019BarclaysLower Price TargetBuy ➝ Overweight$20.00 ➝ $17.00Low
i
9/27/2019WedbushInitiated CoverageOutperformLow
i
9/23/2019Morgan StanleyLower Price TargetEqual Weight$18.00 ➝ $15.00Low
i
7/24/2019WedbushReiterated RatingBuy$22.00Medium
i
6/23/2019WedbushReiterated RatingBuy$22.00Medium
i
5/9/2019WedbushReiterated RatingBuy$22.00High
i
2/8/2019WedbushReiterated RatingBuy$22.00High
i
1/15/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$19.00 ➝ $17.00Low
i
10/18/2018WedbushInitiated CoverageOutperform ➝ Outperform$22.00Low
i
8/9/2018Standpoint ResearchDowngradeBuy ➝ HoldHigh
i
8/9/2018BarclaysBoost Price TargetOverweight ➝ Overweight$18.00 ➝ $20.00Low
i
8/9/2018Stifel NicolausBoost Price TargetHold ➝ Hold$15.00 ➝ $17.00High
i
5/10/2018Craig HallumLower Price TargetBuy ➝ In-Line$24.00 ➝ $17.00High
i
5/10/2018Stifel NicolausReiterated RatingHold ➝ Hold$18.00 ➝ $15.00High
i
3/22/2018Morgan StanleySet Price TargetBuy$20.00Medium
i
Rating by Sanjit Singh at Morgan Stanley
1/23/2018OppenheimerReiterated RatingBuy$23.00Low
i
1/22/2018Canaccord GenuityReiterated RatingBuy$21.00High
i
12/18/2017OppenheimerReiterated RatingBuy$23.00Low
i
11/29/2017OppenheimerReiterated RatingBuy$23.00High
i
11/29/2017Stifel NicolausReiterated RatingHold ➝ Hold$19.00 ➝ $18.00High
i
11/22/2017Morgan StanleyReiterated RatingBuy$18.00N/A
i
11/2/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$18.00N/A
i
8/10/2017OppenheimerReiterated RatingOutperform$26.00 ➝ $23.00High
i
8/9/2017BarclaysLower Price TargetOverweight$22.00 ➝ $21.00Low
i
8/9/2017Raymond JamesLower Price TargetStrong-Buy$24.00 ➝ $22.00Low
i
8/9/2017Deutsche Bank AktiengesellschaftLower Price TargetBuy$25.00 ➝ $23.00Low
i
8/9/2017Canaccord GenuityLower Price TargetBuy$22.00 ➝ $21.00High
i
7/25/2017Morgan StanleyReiterated RatingEqual Weight$19.00 ➝ $18.00Low
i
6/12/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$25.00Medium
i
5/12/2017BarclaysReiterated RatingBuy$22.00Low
i
5/10/2017Stifel NicolausBoost Price TargetHold ➝ Hold$16.00 ➝ $19.00High
i
2/9/2017OppenheimerReiterated RatingOutperform$26.00N/A
i
2/8/2017BarclaysBoost Price TargetOverweight$19.00 ➝ $20.00N/A
i
2/8/2017CitigroupReiterated RatingOutperformN/A
i
2/3/2017Canaccord GenuityReiterated RatingBuy$20.00N/A
i
1/6/2017BarclaysUpgradeEqual Weight ➝ Overweight$17.00 ➝ $19.00N/A
i
Rating by saket kalia at Barclays PLC
11/22/2016UBS GroupReiterated RatingNeutral$15.00 ➝ $16.00N/A
i
11/21/2016OppenheimerReiterated RatingOutperform$26.00N/A
i
11/18/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$25.00N/A
i
11/18/2016Canaccord GenuityReiterated RatingBuyN/A
i
11/18/2016Raymond JamesUpgradeOutperform ➝ Strong-Buy$24.00N/A
i
11/18/2016UBS GroupUpgradeOutperform ➝ Strong-BuyN/A
i
8/11/2016OppenheimerReiterated RatingOutperform$26.00N/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/9/2016BarclaysSet Price TargetHold$20.00 ➝ $19.00N/A
i
Rating by Saket Kalia at Barclays PLC
8/9/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$30.00 ➝ $25.00N/A
i
Rating by Sameer Kalucha at Deutsche Bank Aktiengesellschaft
8/9/2016UBS GroupLower Price TargetNeutral$18.00 ➝ $17.00N/A
i
Rating by Brent Thill at UBS Group AG
5/12/2016Needham & Company LLCReiterated RatingHoldN/A
i
Rating by Scott Zeller at Needham & Company LLC
5/12/2016UBS GroupReiterated RatingNeutral$19.00 ➝ $18.00N/A
i
5/11/2016Canaccord GenuityLower Price TargetBuy$22.00 ➝ $20.00N/A
i
Rating by Richard Davis at Canaccord Genuity
5/11/2016SVB LeerinkLower Price TargetOutperform$23.00 ➝ $22.00N/A
i
4/15/2016BarclaysInitiated CoverageEqual Weight$22.00N/A
i
3/24/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by Benji Star at Deutsche Bank Aktiengesellschaft
3/14/2016Craig HallumBoost Price TargetBuy$26.00N/A
i
3/13/2016OppenheimerReiterated RatingOutperformN/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
3/12/2016SVB LeerinkReiterated RatingOutperform$21.00 ➝ $23.00N/A
i
2/10/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$30.00N/A
i
Rating by Nandan Amladi at Deutsche Bank Aktiengesellschaft
2/10/2016OppenheimerReiterated RatingOutperform$26.00N/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
1/15/2016Standpoint ResearchUpgradeHold ➝ Buy$22.00N/A
i
12/3/2015Deutsche Bank AktiengesellschaftReiterated RatingBuy$30.00N/A
i
Rating by Nandan Amladi at Deutsche Bank Aktiengesellschaft
(Data available from 12/3/2015 forward)
Nuance Communications logo
Nuance Communications, Inc. provides conversational artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. It offers customers high accuracy in automated speech recognition, natural language understanding capabilities, dialog and information management, biometric speaker authentication, text-to-speech, and domain knowledge along with professional services and implementation support. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, Web, and messaging channels. Its Other segment provides voicemail transcription services to mobile operators. The company serves organizations across healthcare, financial services, telecommunications, government, and retail. Nuance Communications, Inc. markets and sells its solutions and technologies directly through sales force, as well as through a network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, telecommunications carriers, and e-commerce Website worldwide. Nuance Communications, Inc. has a strategic partnership with Mila to collaborate on research and advance work in machine learning. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts.
Read More

Today's Range

Now: $42.20
$41.01
$42.53

50 Day Range

MA: $36.03
$31.50
$43.13

52 Week Range

Now: $42.20
$13.51
$43.95

Volume

2,801,678 shs

Average Volume

3,707,992 shs

Market Capitalization

$11.91 billion

P/E Ratio

76.72

Dividend Yield

N/A

Beta

1.02